ClariTrial | Search Clinical Trials

Explore/C4 Therapeutics

Status

Phase

770 results for “C4 Therapeutics”

Page 1 of 52

Completed

Comparison of the Effectiveness of 5% and 10% Dextrose Treatments in Patients With Chronic Shoulder Pain: Ultrasound-Guided Perineural Injection

N/AChronic Shoulder Pain

dextrose

Ankara City Hospital Bilkent120 participants1 site · Turkey (Türkiye)Completes Dec 2025

Compare CT.gov Full analysis →

UNKNOWN

Efficacy and Safety of Tripterygium Wilfordii in Patients With Lupus Nephritis

Phase 2Phase 3Nephritis, Lupus

Tripterygium wilfordii Hook FCyclophosphamideGC

Peking Union Medical College Hospital130 participants1 site · ChinaCompletes Jul 2013

Compare CT.gov Full analysis →

Terminated

Results posted

Phase 4 Study of Obeticholic Acid Evaluating Clinical Outcomes in Patients With Primary Biliary Cholangitis

Phase 4Liver Cirrhosis, Biliary

Obeticholic Acid (OCA)Placebo

Intercept Pharmaceuticals334 participants181 sites · United States, Argentina, AustraliaCompletes Dec 2021

Compare CT.gov Full analysis →

Completed

Results posted

Study to Assess Safety and Effectiveness of Branebrutinib Treatment in Participants With Active Systemic Lupus Erythematosus or Primary Sjögren's Syndrome, or Branebrutinib Treatment Followed by Open-label Abatacept Treatment in Study Participants With Active Rheumatoid Arthritis

Phase 2Autoimmune DisorderRheumatoid ArthritisSystemic Lupus Erythematosus

branebrutinibabataceptbranebrutinib placebo

Bristol-Myers Squibb119 participants81 sites · United States, Argentina, BelgiumCompletes Dec 2022

Compare CT.gov Full analysis →

Completed

Alternating and Direct Current Stimulation for Neuropathic Eye Pain

N/AEye PainNeuropathy, OpticCerebral Injury

DC-Stimulator Plus (NeuroConn GmbH, Germany)Sooma direct current stimulator (Sooma, Finland)

Neil Lagali20 participants1 site · SwedenCompletes Dec 2024

Compare CT.gov Full analysis →

Terminated

Continuous Versus Short Infusions of Ceftazidime in Cystic Fibrosis

Phase 4Cystic FibrosisPseudomonas AeruginosaPulmonary Exacerbation

ceftazidime

Association Nationale pour les Traitements A Domicile, les Innovations et la Recherche120 participants15 sites · France

Compare CT.gov Full analysis →

Terminated

NK510 Cell Therapy for Refractory Systemic Lupus Erythematosus

Early Phase 1Refractory Systemic Lupus Erythematosus

NK510 : allogeneic genetic modified NK

Base Therapeutics (Shanghai) Co., Ltd.4 participants1 site · ChinaCompletes Apr 2026

Compare CT.gov Full analysis →

Completed

Effects of Manual Therapy on Shoulder Function

N/AMusculoskeletal ManipulationsShoulderRange of Motion

Thoracic ManipulationCervical Manipulationglenohumeral posterior glide mobilization+1 more

University of Hartford48 participants1 site · United StatesCompletes Nov 2020

Compare CT.gov Full analysis →

Recruiting

Study of YK012 in Moderate to Severe Systemic Lupus Erythematosus

Phase 1Phase 2Systemic Lupus Erythematosus (SLE)

YK012

Excyte Biopharma Ltd189 participants1 site · ChinaCompletes Jun 2027

Compare CT.gov Full analysis →

UNKNOWN

Correlation of Clinical Types and Complexity of Coronary Artery Disease With Patients' Metabolic Profile

N/ACoronary Artery Disease

metabolomics analysis

AHEPA University Hospital1,050 participants1 site · GreeceCompletes Jun 2021

Compare CT.gov Full analysis →

Terminated

Obeticholic Acid in Pediatric Subjects With Biliary Atresia

Phase 2Biliary Atresia

OCA 0.1mgOCA 1.5mgOCA 5mg

Intercept Pharmaceuticals7 participants17 sites · Belgium, France, GermanyCompletes Mar 2023

Compare CT.gov Full analysis →

Recruiting

Immune Modulation During Palynziq® Treatment in Adults (IMPALA)

Phase 4Phenylketonuria

PegvaliaseMethotrexate

BioMarin Pharmaceutical12 participants12 sites · United StatesCompletes Sep 2027

Compare CT.gov Full analysis →

Completed

A Study of ICP-022 in Patients With Systemic Lupus Erythematosus (SLE)

Phase 1Phase 2Systemic Lupus Erythematosus

ICP-022ICP-022ICP-022+1 more

Beijing InnoCare Pharma Tech Co., Ltd.60 participants11 sites · ChinaCompletes Apr 2022

Compare CT.gov Full analysis →

By Invitation

Anti-CD19 CAR-T Cell Therapy for Patients With Refractory Systemic Lupus Erythematosus

N/ASystem Lupus Erythematosus(SLE)

CAR T cells chimeric antigen receptor cells

N.N. Alexandrov National Cancer Centre12 participants1 site · BelarusCompletes Jun 2028

Compare CT.gov Full analysis →

Not Yet Recruiting

Efficacy and Safety of Low-dose IL-2 in SLE Patients With CMV Viremia

Phase 2SLE (Systemic Lupus)CMV

Interleukin-2 (IL-2)Ganciclovir (GCV)

Peking University People's Hospital100 participants1 site · ChinaCompletes Sep 2025

Compare CT.gov Full analysis →

1–15 of 770

Explore/C4 Therapeutics

Status

Phase

770 results for “C4 Therapeutics”

Page 1 of 52

Completed

Comparison of the Effectiveness of 5% and 10% Dextrose Treatments in Patients With Chronic Shoulder Pain: Ultrasound-Guided Perineural Injection

N/AChronic Shoulder Pain

dextrose

Ankara City Hospital Bilkent120 participants1 site · Turkey (Türkiye)Completes Dec 2025

Compare CT.gov Full analysis →

UNKNOWN

Efficacy and Safety of Tripterygium Wilfordii in Patients With Lupus Nephritis

Phase 2Phase 3Nephritis, Lupus

Tripterygium wilfordii Hook FCyclophosphamideGC

Peking Union Medical College Hospital130 participants1 site · ChinaCompletes Jul 2013

Compare CT.gov Full analysis →

Terminated

Results posted

Phase 4 Study of Obeticholic Acid Evaluating Clinical Outcomes in Patients With Primary Biliary Cholangitis

Phase 4Liver Cirrhosis, Biliary

Obeticholic Acid (OCA)Placebo

Intercept Pharmaceuticals334 participants181 sites · United States, Argentina, AustraliaCompletes Dec 2021

Compare CT.gov Full analysis →

Completed

Results posted

Phase 2Autoimmune DisorderRheumatoid ArthritisSystemic Lupus Erythematosus

branebrutinibabataceptbranebrutinib placebo

Bristol-Myers Squibb119 participants81 sites · United States, Argentina, BelgiumCompletes Dec 2022

Compare CT.gov Full analysis →

Completed

Alternating and Direct Current Stimulation for Neuropathic Eye Pain

N/AEye PainNeuropathy, OpticCerebral Injury

DC-Stimulator Plus (NeuroConn GmbH, Germany)Sooma direct current stimulator (Sooma, Finland)

Neil Lagali20 participants1 site · SwedenCompletes Dec 2024

Compare CT.gov Full analysis →

Terminated

Continuous Versus Short Infusions of Ceftazidime in Cystic Fibrosis

Phase 4Cystic FibrosisPseudomonas AeruginosaPulmonary Exacerbation

ceftazidime

Association Nationale pour les Traitements A Domicile, les Innovations et la Recherche120 participants15 sites · France

Compare CT.gov Full analysis →

Terminated

NK510 Cell Therapy for Refractory Systemic Lupus Erythematosus

Early Phase 1Refractory Systemic Lupus Erythematosus

NK510 : allogeneic genetic modified NK

Base Therapeutics (Shanghai) Co., Ltd.4 participants1 site · ChinaCompletes Apr 2026

Compare CT.gov Full analysis →

Completed

Effects of Manual Therapy on Shoulder Function

N/AMusculoskeletal ManipulationsShoulderRange of Motion

Thoracic ManipulationCervical Manipulationglenohumeral posterior glide mobilization+1 more

University of Hartford48 participants1 site · United StatesCompletes Nov 2020

Compare CT.gov Full analysis →

Recruiting

Study of YK012 in Moderate to Severe Systemic Lupus Erythematosus

Phase 1Phase 2Systemic Lupus Erythematosus (SLE)

YK012

Excyte Biopharma Ltd189 participants1 site · ChinaCompletes Jun 2027

Compare CT.gov Full analysis →

UNKNOWN

Correlation of Clinical Types and Complexity of Coronary Artery Disease With Patients' Metabolic Profile

N/ACoronary Artery Disease

metabolomics analysis

AHEPA University Hospital1,050 participants1 site · GreeceCompletes Jun 2021

Compare CT.gov Full analysis →

Terminated

Obeticholic Acid in Pediatric Subjects With Biliary Atresia

Phase 2Biliary Atresia

OCA 0.1mgOCA 1.5mgOCA 5mg

Intercept Pharmaceuticals7 participants17 sites · Belgium, France, GermanyCompletes Mar 2023

Compare CT.gov Full analysis →

Recruiting

Immune Modulation During Palynziq® Treatment in Adults (IMPALA)

Phase 4Phenylketonuria

PegvaliaseMethotrexate

BioMarin Pharmaceutical12 participants12 sites · United StatesCompletes Sep 2027

Compare CT.gov Full analysis →

Completed

A Study of ICP-022 in Patients With Systemic Lupus Erythematosus (SLE)

Phase 1Phase 2Systemic Lupus Erythematosus

ICP-022ICP-022ICP-022+1 more

Beijing InnoCare Pharma Tech Co., Ltd.60 participants11 sites · ChinaCompletes Apr 2022

Compare CT.gov Full analysis →

By Invitation

Anti-CD19 CAR-T Cell Therapy for Patients With Refractory Systemic Lupus Erythematosus

N/ASystem Lupus Erythematosus(SLE)

CAR T cells chimeric antigen receptor cells

N.N. Alexandrov National Cancer Centre12 participants1 site · BelarusCompletes Jun 2028

Compare CT.gov Full analysis →

Not Yet Recruiting

Efficacy and Safety of Low-dose IL-2 in SLE Patients With CMV Viremia

Phase 2SLE (Systemic Lupus)CMV

Interleukin-2 (IL-2)Ganciclovir (GCV)

Peking University People's Hospital100 participants1 site · ChinaCompletes Sep 2025

Compare CT.gov Full analysis →

1–15 of 770